2011
DOI: 10.1002/mds.23950
|View full text |Cite
|
Sign up to set email alerts
|

Glucocerebrosidase gene mutations are associated with Parkinson's disease in Russia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
8
0
3

Year Published

2012
2012
2018
2018

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 30 publications
(11 citation statements)
references
References 6 publications
0
8
0
3
Order By: Relevance
“…Although parkinsonian symptoms in patients with Gaucher's disease were initially thought to be poorly responsive to levodopa treatment, 19 most subsequent studies have reported good or excellent responses, similar to those in patients with sporadic Parkinson’s disease. 17,30,34,39,41,62 …”
Section: Clinical Features Of Gba-associated Parkinsonismmentioning
confidence: 99%
“…Although parkinsonian symptoms in patients with Gaucher's disease were initially thought to be poorly responsive to levodopa treatment, 19 most subsequent studies have reported good or excellent responses, similar to those in patients with sporadic Parkinson’s disease. 17,30,34,39,41,62 …”
Section: Clinical Features Of Gba-associated Parkinsonismmentioning
confidence: 99%
“…Mutations in GBA (glucosidase, beta, acid), encoding the lysosomal enzyme glucocerebrosidase, are important risk factors for Parkinson disease (PD) worldwide. 1 Positive association between GBA mutations and PD was demonstrated in various populations, including Asians, [2][3][4][5][6] Europeans, [7][8][9][10][11][12] North Africans, 13 North Americans [14][15][16] and South Americans, [17][18][19][20] but most frequently among Jews of Ashkenazi origin. 21,22 When inherited from both parents, GBA mutations cause Gaucher disease (GD), a lysosomal storage disorder with 3 clinical types: nonneuropathic (type I), acute neuropathic (type II), and chronic neuropathic (type III).…”
mentioning
confidence: 99%
“…Mutations in the gene that encodes glucoserebrosidase 1 ( GBA ) have been identified as the most common known genetic risk factor for the development of Parkinson's disease (PD) . Association studies have demonstrated a high incidence of GBA mutations in PD patients, particularly those with early disease onset . PD patients are approximately 6 times more likely to carry GBA mutations than healthy controls.…”
mentioning
confidence: 99%
“…1 Association studies have demonstrated a high incidence of GBA mutations in PD patients, particularly those with early disease onset. [2][3][4] PD patients are approximately 6 times more likely to carry GBA mutations than healthy controls.…”
mentioning
confidence: 99%